{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:08:24Z","timestamp":1791151704883,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T00:00:00Z","timestamp":1433548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00417-015-3073-4","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T03:22:09Z","timestamp":1433474529000},"page":"1721-1728","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The use of human cornea organotypic cultures to study herpes simplex virus type 1 (HSV-1)-induced inflammation"],"prefix":"10.1007","volume":"253","author":[{"given":"Peter","family":"Drevets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Chucair-Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarsini","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Jinkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Karamichos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J. J.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,6]]},"reference":[{"issue":"8","key":"3073_CR1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","volume":"296","author":"F Xu","year":"2006","unstructured":"Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296(8):964\u2013973","journal-title":"JAMA"},{"issue":"8","key":"3073_CR2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/archopht.1989.01070020221029","volume":"107","author":"TJ Liesegang","year":"1989","unstructured":"Liesegang TJ, Melton LJ III, Daly PJ, Ilstrup DM (1989) Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107(8):1155\u20131159","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"3073_CR3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/archophthalmol.2010.187","volume":"128","author":"RC Young","year":"2010","unstructured":"Young RC, Hodge DO, Liesegang TJ, Baratz KH (2010) Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976\u20132007: the effect of oral antiviral prophylaxis. Arch Ophthalmol 128(9):1178\u20131183","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"3073_CR4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/ICO.0b013e31828f9d64","volume":"32","author":"PJ Dubord","year":"2013","unstructured":"Dubord PJ, Evans GD, Macsai MS, Mannis MJ, Glasser DB, Strong DM, Noel L, Fehily D (2013) Eye banking and corneal transplantation communicable adverse incidents: current status and project NOTIFY. Cornea 32(8):1155\u20131166","journal-title":"Cornea"},{"issue":"1","key":"3073_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/599329","volume":"200","author":"L Remeijer","year":"2009","unstructured":"Remeijer L, Duan R, van Dun JM, Wefers Bettink MA, Osterhaus AD, Verjans GM (2009) Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. J Infect Dis 200(1):11\u201319","journal-title":"J Infect Dis"},{"issue":"2","key":"3073_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00003226-200403000-00003","volume":"23","author":"VM Borderie","year":"2004","unstructured":"Borderie VM, Meritet JF, Chaumeil C, Rozenberg F, Baudrimont M, Touzeau O, Bourcier T, Laroche L (2004) Culture-proven herpetic keratitis after penetrating keratoplasty in patients with no previous history of herpes disease. Cornea 23(2):118\u2013124","journal-title":"Cornea"},{"issue":"12","key":"3073_CR7","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1086\/648474","volume":"200","author":"ER Richter","year":"2009","unstructured":"Richter ER, Dias JK, Gilbert JE, Atherton SS (2009) Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck. J Infect Dis 200(12):1901\u20131906","journal-title":"J Infect Dis"},{"key":"3073_CR8","volume":"69","author":"O Alekseev","year":"2012","unstructured":"Alekseev O, Tran AH, Azizkhan-Clifford J (2012) Ex vivo organotypic corneal model of acute epithelial herpes simplex virus type I infection. J Vis Exp 69, e3631","journal-title":"J Vis Exp"},{"key":"3073_CR9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.preteyeres.2013.06.003","volume":"36","author":"K Bryant-Hudson","year":"2013","unstructured":"Bryant-Hudson K, Conrady CD, Carr DJ (2013) Type I interferon and lymphangiogenesis in the HSV-1 infected cornea - are they beneficial to the host? Prog Retin Eye Res 36:281\u2013291","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"3073_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cm.20326","volume":"66","author":"D Karamichos","year":"2009","unstructured":"Karamichos D, Lakshman N, Petroll WM (2009) An experimental model for assessing fibroblast migration in 3-D collagen matrices. Cell Motil Cytoskeleton 66(1):1\u20139","journal-title":"Cell Motil Cytoskeleton"},{"issue":"3","key":"3073_CR11","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1167\/iovs.09-3860","volume":"51","author":"D Karamichos","year":"2010","unstructured":"Karamichos D, Guo XQ, Hutcheon AE, Zieske JD (2010) Human corneal fibrosis: an in vitro model. Invest Ophthalmol Vis Sci 51(3):1382\u20131388","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3073_CR12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/jfb3040760","volume":"3","author":"D Karamichos","year":"2012","unstructured":"Karamichos D, Zareian R, Guo X, Hutcheon AE, Ruberti JW, Zieske JD (2012) Novel Model for Keratoconus Disease. J Funct Biomater 3(4):760\u2013775","journal-title":"J Funct Biomater"},{"issue":"8","key":"3073_CR13","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.4049\/jimmunol.178.8.5166","volume":"178","author":"BA Austin","year":"2007","unstructured":"Austin BA, Halford WP, Williams BR, Carr DJ (2007) Oligoadenylate synthetase\/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea. J Immunol 178(8):5166\u20135172","journal-title":"J Immunol"},{"issue":"18","key":"3073_CR14","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1128\/JVI.77.18.10037-10046.2003","volume":"77","author":"DJ Carr","year":"2003","unstructured":"Carr DJ, Chodosh J, Ash J, Lane TE (2003) Effect of anti-CXCL10 monoclonal antibody on herpes simplex virus type 1 keratitis and retinal infection. J Virol 77(18):10037\u201310046","journal-title":"J Virol"},{"issue":"6","key":"3073_CR15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/107999099313749","volume":"19","author":"J He","year":"1999","unstructured":"He J, Ichimura H, Iida T, Minami M, Kobayashi K, Kita M, Sotozono C, Tagawa YI, Iwakura Y, Imanishi J (1999) Kinetics of cytokine production in the cornea and trigeminal ganglion of C57BL\/6 mice after corneal HSV-1 infection. J Interferon Cytokine Res 19(6):609\u2013615","journal-title":"J Interferon Cytokine Res"},{"issue":"1","key":"3073_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.151.1.277","volume":"151","author":"HF Staats","year":"1993","unstructured":"Staats HF, Lausch RN (1993) Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy. J Immunol 151(1):277\u2013283","journal-title":"J Immunol"},{"issue":"Pt 7","key":"3073_CR17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1099\/0022-1317-83-7-1579","volume":"83","author":"TH Stumpf","year":"2002","unstructured":"Stumpf TH, Case R, Shimeld C, Easty DL, Hill TJ (2002) Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids. J Gen Virol 83(Pt 7):1579\u20131590","journal-title":"J Gen Virol"},{"issue":"10","key":"3073_CR18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002278","volume":"7","author":"T Wuest","year":"2011","unstructured":"Wuest T, Zheng M, Efstathiou S, Halford WP, Carr DJ (2011) The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization. PLoS Pathog 7(10), e1002278","journal-title":"PLoS Pathog"},{"issue":"16","key":"3073_CR19","doi-asserted-by":"crossref","first-page":"8559","DOI":"10.1128\/JVI.00505-12","volume":"86","author":"HW Yao","year":"2012","unstructured":"Yao HW, Chen SH, Li C, Tung YY, Chen SH (2012) Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice. J Virol 86(16):8559\u20138567","journal-title":"J Virol"},{"key":"3073_CR20","unstructured":"Karamichos D, Hutcheon AE, Zieske JD (2014) Reversal of fibrosis by TGF-beta3 in a 3D in vitro model. Exp Eye Res 12431\u201336"},{"issue":"2","key":"3073_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cellimm.2007.01.001","volume":"243","author":"T Wuest","year":"2006","unstructured":"Wuest T, Farber J, Luster A, Carr DJ (2006) CD4+ T cell migration into the cornea is reduced in CXCL9 deficient but not CXCL10 deficient mice following herpes simplex virus type 1 infection. Cell Immunol 243(2):83\u201389","journal-title":"Cell Immunol"},{"issue":"5","key":"3073_CR22","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1167\/iovs.13-13779","volume":"55","author":"D Yuen","year":"2014","unstructured":"Yuen D, Grimaldo S, Sessa R, Ecoiffier T, Truong T, Huang E, Bernas M, Daley S, Witte M, Chen L (2014) Role of angiopoietin-2 in corneal lymphangiogenesis. Invest Ophthalmol Vis Sci 55(5):3320\u20133327","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"3073_CR23","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ajpath.2013.06.014","volume":"183","author":"KM Bryant-Hudson","year":"2013","unstructured":"Bryant-Hudson KM, Chucair-Elliott AJ, Conrady CD, Cohen A, Zheng M, Carr DJ (2013) HSV-1 targets lymphatic vessels in the eye and draining lymph node of mice leading to edema in the absence of a functional type I interferon response. Am J Pathol 183(4):1233\u20131242","journal-title":"Am J Pathol"},{"issue":"2","key":"3073_CR24","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1167\/iovs.13-13523","volume":"55","author":"JE Knickelbein","year":"2014","unstructured":"Knickelbein JE, Buela KA, Hendricks RL (2014) Antigen-presenting cells are stratified within normal human corneas and are rapidly mobilized during ex vivo viral infection. Invest Ophthalmol Vis Sci 55(2):1118\u20131123","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3073_CR25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/ni.2797","volume":"15","author":"PR Taylor","year":"2014","unstructured":"Taylor PR, Roy S, Leal SM Jr, Sun Y, Howell SJ, Cobb BA, Li X, Pearlman E (2014) Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nat Immunol 15(2):143\u2013151","journal-title":"Nat Immunol"},{"issue":"1","key":"3073_CR26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4049\/jimmunol.172.1.550","volume":"172","author":"RS Klein","year":"2004","unstructured":"Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD (2004) IFN-inducible protein 10\/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis. J Immunol 172(1):550\u2013559","journal-title":"J Immunol"},{"issue":"2","key":"3073_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000236006","volume":"151","author":"M Anthoni","year":"2010","unstructured":"Anthoni M, Fyhrquist N, Lehtimaki S, Alenius H, Wolff H, Lauerma A (2010) Smad3 regulates dermal cytokine and chemokine expression and specific antibody production in murine responses to a respiratory chemical sensitizer. Int Arch Allergy Immunol 151(2):155\u2013167","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"3073_CR28","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.4049\/jimmunol.146.10.3437","volume":"146","author":"JA Elias","year":"1991","unstructured":"Elias JA, Lentz V, Cummings PJ (1991) Transforming growth factor-beta regulation of IL-6 production by unstimulated and IL-1-stimulated human fibroblasts. J Immunol 146(10):3437\u20133443","journal-title":"J Immunol"},{"issue":"13","key":"3073_CR29","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1091\/mbc.E13-01-0017","volume":"24","author":"O Mungunsukh","year":"2013","unstructured":"Mungunsukh O, Day RM (2013) Transforming growth factor-beta1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism. Mol Biol Cell 24(13):2088\u20132097","journal-title":"Mol Biol Cell"},{"issue":"1\u20132","key":"3073_CR30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.regpep.2005.03.008","volume":"130","author":"R Naim","year":"2005","unstructured":"Naim R, Chang RC, Alfano SS, Riedel F, Bayerl C, Sadick H, Bran G, Hormann K (2005) Targeting TGF-beta1 increases hepatocyte growth factor (HGF\/SF) levels in external auditory canal cholesteatoma (EACC) epithelial cell culture. Regul Pept 130(1\u20132):75\u201380","journal-title":"Regul Pept"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3073-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-015-3073-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-015-3073-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T04:27:18Z","timestamp":1691728038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-015-3073-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,6]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3073"],"URL":"https:\/\/doi.org\/10.1007\/s00417-015-3073-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,6]]}}}